These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11797611)

  • 1. Evaluation of commercially available rapid assays: a manufacturer's perspective.
    Hart I
    J Clin Microbiol; 2001 Dec; 39(12):4601. PubMed ID: 11797611
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic tests: Clostridium difficile].
    Okada J
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():210-3. PubMed ID: 16111229
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of two commercially available enzyme immunoassays for detection of Clostridium difficile in stool specimens.
    Altaie SS; Meyer P; Dryja D
    J Clin Microbiol; 1994 Jan; 32(1):51-3. PubMed ID: 8126205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of six commercial assays for the rapid detection of Clostridium difficile toxin and/or antigen in stool specimens.
    Vanpoucke H; De Baere T; Claeys G; Vaneechoutte M; Verschraegen G
    Clin Microbiol Infect; 2001 Feb; 7(2):55-64. PubMed ID: 11298143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens.
    Merz CS; Kramer C; Forman M; Gluck L; Mills K; Senft K; Steiman I; Wallace N; Charache P
    J Clin Microbiol; 1994 May; 32(5):1142-7. PubMed ID: 8051237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tox-A Test for Clostridium difficile.
    Wilkins TD; Lyerly DM
    J Clin Microbiol; 1994 Sep; 32(9):2338. PubMed ID: 7695729
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens.
    Rüssmann H; Panthel K; Bader RC; Schmitt C; Schaumann R
    Eur J Clin Microbiol Infect Dis; 2007 Feb; 26(2):115-9. PubMed ID: 17211606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chapter 2-12-7. Anaerobic infections (individual fields): antibiotic-associated diarrhea and enterocolitis.
    ;
    J Infect Chemother; 2011 Jul; 17 Suppl 1():137-9. PubMed ID: 21728113
    [No Abstract]   [Full Text] [Related]  

  • 9. Glutamate dehydrogenase for laboratory diagnosis of Clostridium difficile infection.
    Goldenberg SD; Cliff PR; French GL
    J Clin Microbiol; 2010 Aug; 48(8):3050-1; author reply 3051. PubMed ID: 20668302
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection.
    Kawada M; Annaka M; Kato H; Shibasaki S; Hikosaka K; Mizuno H; Masuda Y; Inamatsu T
    J Infect Chemother; 2011 Dec; 17(6):807-11. PubMed ID: 21725661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentre evaluation of a commercial test for the rapid diagnosis of Clostridium difficile-mediated antibiotic-associated diarrhoea.
    Bentley AH; Patel NB; Sidorczuk M; Loy P; Fulcher J; Dexter P; Richards J; Borriello SP; Zak KW; Thorn EM
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):788-90. PubMed ID: 9923521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile-associated diarrhea in hospitalized patients.
    van den Berg RJ; Bruijnesteijn van Coppenraet LS; Gerritsen HJ; Endtz HP; van der Vorm ER; Kuijper EJ
    J Clin Microbiol; 2005 Oct; 43(10):5338-40. PubMed ID: 16208012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing ImmunoCard with two EIA assays for Clostridium difficile toxins.
    Chan EL; Seales D; Drum H
    Clin Lab Sci; 2009; 22(2):81-5. PubMed ID: 19534439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of three enzyme immunoassays for detection of Clostridium difficile toxins A and B].
    Ould-Hocine ZF; Djibo N; Deforges L; Legrand P; Cattoir V
    Pathol Biol (Paris); 2008; 56(7-8):424-8. PubMed ID: 18824307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples.
    Landry ML; Topal J; Ferguson D; Giudetti D; Tang Y
    J Clin Microbiol; 2001 May; 39(5):1855-8. PubMed ID: 11326003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of VIDAS CDAB and CDA immunoassay for the detection of Clostridium difficile in a tcdA- tcdB+ C. difficile prevalent area.
    Shin BM; Lee EJ; Kuak EY; Yoo SJ
    Anaerobe; 2009 Dec; 15(6):266-9. PubMed ID: 19772927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clostridium difficile].
    Okada J
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():224-6. PubMed ID: 20942043
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG.
    Biller JA; Katz AJ; Flores AF; Buie TM; Gorbach SL
    J Pediatr Gastroenterol Nutr; 1995 Aug; 21(2):224-6. PubMed ID: 7472911
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory diagnosis of Clostridium difficile-associated gastrointestinal disease: comparison of a monoclonal antibody enzyme immunoassay for toxins A and B with a monoclonal antibody enzyme immunoassay for toxin A only and two cytotoxicity assays.
    Doern GV; Coughlin RT; Wu L
    J Clin Microbiol; 1992 Aug; 30(8):2042-6. PubMed ID: 1500512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the true burden of Clostridium difficile disease?
    Wren MW; Coen PG; Shetty NP
    J Hosp Infect; 2007 Oct; 67(2):196-7. PubMed ID: 17884251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.